CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851170950
- Phone
- 737 203 5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-09 | ALLEN SIMON Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,246 | 70,246 | ||
| 2022-11-01 | Calloway Nathaniel Director | Grant or award · Stock Option (right to buy) | +59,149 | 59,149 | ||
| 2022-09-28 | English Aron R. Director | Grant or award | +1,703,577 | $2.81 | $4.8M | 5,066,290 |
| 2022-09-28 | English Aron R. Director | Grant or award · Common Stock Purchase Warrant (right to buy) | +1,703,577 | $0.13 | $213K | 1,703,577 |
| 2022-06-27 | ALLEN SIMON Chief Executive Officer | Grant or award · Stock Option (right to buy) | +77,457 | 77,457 | ||
| 2022-06-01 | Cundy Kenneth C Chief Scientific Officer | Grant or award · Option to purchase Common Stock | +350,169 | 350,169 | ||
| 2022-04-21 | Lawler Joseph F. Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-04-21 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-04-21 | Parschauer Karah Herdman Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-04-21 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-04-21 | Kupchyk Areta Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-04-21 | English Aron R. Director | Grant or award · Stock Option (right to buy) | +30,425 | 30,425 | ||
| 2022-02-07 | ALLEN SIMON Chief Executive Officer | Grant or award · Option to purchase Common Stock | +625,000 | 625,000 | ||
| 2021-12-17 | English Aron R. Director | Purchase | +400 | $6.59 | $3K | 3,362,713 |
| 2021-12-14 | English Aron R. Director | Purchase | +412 | $5.90 | $2K | 3,362,313 |
| 2021-12-03 | English Aron R. Director | Purchase | +4,500 | $5.93 | $27K | 3,361,901 |
| 2021-12-02 | English Aron R. Director | Purchase | +13,836 | $5.30 | $73K | 3,357,401 |
| 2021-05-06 | English Aron R. Director | Grant or award | +714,250 | $7.00 | $5.0M | 3,343,565 |
| 2021-05-06 | English Aron R. Director | Grant or award | +714,286 | $7.00 | $5.0M | 3,343,601 |
Page 3 of 3 · 59 trades